In vitro pharmacological profile of PHA-022121, a small molecule bradykinin B 2 receptor antagonist in clinical development

PHA-022121 is a novel small molecule bradykinin B2 receptor antagonist, in clinical development for the treatment and prevention of hereditary angioedema

Read more